Figure 4 Functional luminal imaging probe

Slides:

Advertisements

Similar presentations

Figure 4 PET imaging in experimental pancreatic cancer

Advertisements

Figure 1 Proposed risk stratification for patients with NAFLD

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 3 Low-grade inflammation in FGID

Figure 1 Imaging of a depressed intramucosal carcinoma

Figure 4 Activation of clopidogrel via cytochrome P450

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 1 Worldwide incidence of CCA

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 1 Organs involved in coeliac-disease-associated autoimmunity

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 1 Biosimilar development process

Figure 2 Approach to diagnosis and management of food allergy

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 6 Combination therapy for HCC

Figure 2 Modelling the effect of HCV treatment on reinfection in people who inject drugs Figure 2 | Modelling the effect of HCV treatment on reinfection.

Figure 4 Proinflammatory immune cells and their crosstalk in patients with IBD Figure 4 | Proinflammatory immune cells and their crosstalk in patients.

Figure 1 Definition and concept of ACLF

Figure 2 Switching of biologic agents and biosimilars

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 3 High-resolution manometry of achalasia subtypes

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 3 Example wireless motility recording

Figure 2 Key metrics of pressure topography (Clouse)

to the liver and promote patient-derived xenograft tumour growth

Figure 7 Example colonic high-resolution manometry

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 1 Pseudorelaxation as a consequence of

Figure 3 A patient with aortic and mitral stenosis

Figure 1 Environmental factors contributing to IBD pathogenesis

Figure 4 Example plots of high-resolution gastroduodenal manometry

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 4 Examples of reflux episodes on pH and pH-impedance monitoring

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 3 Clinical algorithms in the management of NASH and diabetes mellitus Figure 3 | Clinical algorithms in the management of NASH and diabetes mellitus.

Figure 2 13C-octanoic acid gastric emptying breath test

in the UK (1961–2012), France (1961–2014) and Italy (1961–2010)

Figure 5 Representative barium defecography images

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 2 Metrics from oesophageal high-resolution

Figure 6 Possible therapeutic targets to decrease hepatic steatosis

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 5 High-resolution manometry studies performed

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 3 Optical coherence tomography images of specialized intestinal

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

with broad-spectrum antibiotics

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 6 Assessment of colonic transit time with radiopaque markers

Figure 5 Systems biological model of IBS

HRM findings in the two groups (those with delayed GE (blue bars) and those with normal GE (orange bars)), using the Chicago classification (v.3) (see.

Figure 4 Local species pools that contribute to the

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Advances in Management of Esophageal Motility Disorders

Figure 2 Lifelong influences on the gut microbiome from

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 8 Assessment of colonic tone using a barostat device

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 2 Enhanced imaging techniques and autofluorescence endoscopy for Barrett oesophagus Figure 2 | Enhanced imaging techniques and autofluorescence.

Figure 3 Endomicroscopy for optical intestinal biopsy

Presentation transcript:

Figure 4 Functional luminal imaging probe study demonstrating decreased oesophagogastric junction distensibility Figure 4 | Functional luminal imaging probe study demonstrating decreased oesophagogastric junction distensibility. Oesophagogastric junction (EGJ) distensibility in this patient with achalasia is 1.3 mm2 per mmHg. The optimal threshold for detecting achalasia is <2.8 mm2 per mmHg. a | The positioning of the functional luminal imaging probe (FLIP) device at the EGJ along with the stepwise distension protocol. b | The corresponding FLIP display and calculated values for cross-sectional area, pressure and EGJ distensibility index are shown. CSA, cross-sectional area; FLIP, functional lumen impedance planimetry. Kahrilas, P. J. et al. (2017) Advances in the management of oesophageal motility disorders in the era of high-resolution manometry: a focus on achalasia syndromes Nat. Rev. Gastroenterol. Hepatol. doi:10.1038/nrgastro.2017.132